Reich & Binstock
Free Initial Consultation
Toll Free: 877-643-3099
Local: 713-352-7883
877-643-3099 713-352-7883

January 2016 Archives

Risperdal company owes South Carolina $124 million

It appears that Janssen Pharmaceuticals and other defendants behind the manufacture and marketing of the antipsychotic drug Risperdal (risperidone) owe the state of South Carolina $124 million. The U.S. Supreme Court on Jan. 11 refused to review Janssen's appeal of a $124 million civil penalty that the state imposed for not disclosing the drug's risks, notably the risk of the enlargement of male breasts, a condition known as gynecomastia.

Risperdal company owes South Carolina $124 million

Risperdal Gyne Illustration.jpgIt appears that Janssen Pharmaceuticals and other defendants behind the manufacture and marketing of the antipsychotic drug Risperdal (risperidone) owe the state of South Carolina $124 million. The U.S. Supreme Court on Jan. 11 refused to review Janssen's appeal of a $124 million civil penalty that the state imposed for not disclosing the drug's risks, notably the risk of the enlargement of male breasts, a condition known as gynecomastia.

Volkswagen sales down; VW faces Justice Department suit

The situation seems to worsen for Volkswagen, nearly four months since it was  rocked by a scandal centered on the corporation's admitted cheating on auto emissions standards. On the other hand, things might soon look up for dealers, consumers and others who have filed Volkswagen lawsuits in an attempt to be made whole after buying vehicles that were not as advertised.

Volkswagen sales down; VW faces Justice Department suit

The situation seems to worsen for Volkswagen, nearly four months since it wasVW-Emblem.jpg rocked by a scandal centered on the corporation's admitted cheating on auto emissions standards. On the other hand, things might soon look up for dealers, consumers and others who have filed Volkswagen lawsuits in an attempt to be made whole after buying vehicles that were not as advertised.

Boston Uterine Cancer Risk Study Published

The January-February 2016 edition of the medical journal Women's Health Issues will publish what might be considered the U.S. Food and Drug Administration's "I Told You So" study. In the piece, Boston University Medical Center researchers validate the risk that an electronic uterine fibroid treatment known as laparoscopic power morcellation can spread previously undetected uterine cancer.

Boston Uterine Cancer Risk Study Published

morcellator.jpgThe January-February 2016 edition of the medical journal Women's Health Issues will publish what might be considered the U.S. Food and Drug Administration's "I Told You So" study. In the piece, Boston University Medical Center researchers validate the risk that an electronic uterine fibroid treatment known as laparoscopic power morcellation can spread previously undetected uterine cancer.

Robotic surgeries: procedures worth being wary about

There is a line, attributed in some instances to "Star Trek" creator Gene Roddenberry, that goes something like, a lot of science fact wouldn't exist without science fiction. The premise of the statement is that many advances of science first were imagined and written about by dreamers.

Robotic surgeries: procedures worth being wary about

There is a line, attributed in some instances to "Star Trek" creator Gene Roddenberry, that goes something like, a lot of science fact wouldn't exist without science fiction. The premise of the statement is that many advances of science first were imagined and written about by dreamers.

Research validates Zofran risk of birth defects

Long before there were Zofran lawsuits, there were studies that showed a relationship between the anti-nausea drug and birth defects. These studies would appear to vindicate the parents who have filed lawsuits against defendant GlaxoSmithKline, the drug's manufacturer.

Research validates Zofran risk of birth defects

Birth_Defects_Baby.jpgLong before there were Zofran lawsuits, there were studies that showed a relationship between the anti-nausea drug and birth defects. These studies would appear to vindicate the parents who have filed lawsuits against defendant GlaxoSmithKline, the drug's manufacturer.

Contact Us

Contact Us For Legal Advice

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Map & Directions